About Jagath Reddy Junutula
Form D filings for Aarvik Therapeutics from 2021 to 2024 list Jagath Reddy Junutula as chief executive officer and director.
Jagath Reddy Junutula first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Jagath Reddy Junutula in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jagath Reddy Junutula works with at each company, as listed on that company's latest Form D.
Aarvik Therapeutics, Inc. · Form D, Dec 11, 2024